Delivery Order SPE2DB22D3016-SPE2DB25FBFD8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 230-21 microgram inhalers (12-gram units) with a contract ceiling value of $6,737.52. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $2,091.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,025.54 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm). This is a firm fixed price delivery order with no set-aside designation, issued as a competitively awarded contract. The order is scheduled for ultimate completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 9, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm), a commonly prescribed bronchodilator medication used in respiratory care. This firm fixed-price delivery order, valued at $4,376.72, represents a non-competitive award and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gram units) with a ceiling value of $9,743.54. This competitive award, with a firm fixed price structure and no set-aside designation, is scheduled for completion by July 21, 2025. The contract represents a continuation of the company's pharmaceutical supply services under its existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 45/21 mcg inhalers (12 gm) with a ceiling value of $6,252.22. This firm fixed-price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.54 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhalers (8 grams) with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFD8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) with a ceiling value of $1,814.66. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The ultimate completion date is set for August 18, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger contract vehicle. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. The current delivery order for respiratory medications supports the Defense Health Agency and other federal healthcare systems' ongoing pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/15/25 |